| Drug General Information |
| Drug ID |
D0Y1RO
|
| Former ID |
DNC003396
|
| Drug Name |
Novo Nordisk a/S Compound
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C9H6INO5
|
| Canonical SMILES |
C1=CC(=C(C=C1I)C(=O)O)NC(=O)C(=O)O
|
| InChI |
1S/C9H6INO5/c10-4-1-2-6(5(3-4)8(13)14)11-7(12)9(15)16/h1-3H,(H,11,12)(H,13,14)(H,15,16)
|
| InChIKey |
SHSWHSQPJKMCPN-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
838183, 5491794, 7885525, 8151304, 14777687, 26697337, 29221028, 46391793, 46505054, 51706889, 103377734, 104012042, 104298845, 126407222, 136121628, 137102731, 142386587, 160965839, 162998100, 233541125
|
| Target and Pathway |
| Target(s) |
mRNA of Protein tyrosine phosphatase-1B |
Target Info |
Inhibitor |
[1]
|
|---|
|
KEGG Pathway
|
Adherens junction
|
|
Insulin signaling pathway
|
|
NetPath Pathway
|
FSH Signaling Pathway
|
|
PANTHER Pathway
|
Cadherin signaling pathway
|
|
Pathway Interaction Database
|
Insulin Pathway
|
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
|
Signaling events mediated by PTP1B
|
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
|
Signaling events mediated by TCPTP
|
|
IGF1 pathway
|
|
EGF receptor (ErbB1) signaling pathway
|
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
PDGFR-beta signaling pathway
|
|
N-cadherin signaling events
|
|
Reactome
|
Integrin alphaIIb beta3 signaling
|
|
Regulation of IFNG signaling
|
|
Regulation of IFNA signaling
|
|
Growth hormone receptor signaling
|
|
WikiPathways
|
Insulin Signaling
|
|
Growth hormone receptor signaling
|
|
Leptin signaling pathway
|
|
Interferon gamma signaling
|
|
Interferon alpha/beta signaling
|
|
Integrin alphaIIb beta3 signaling
|
| References |
| REF 1 | How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. |
|---|
